DoD awards $6.7M for Analytical Laboratory Instruments, with Abbott Laboratories Inc. as the contractor
Contract Overview
Contract Amount: $6,702,151 ($6.7M)
Contractor: Abbott Laboratories Inc.
Awarding Agency: Department of Defense
Start Date: 2021-08-01
End Date: 2026-07-31
Contract Duration: 1,825 days
Daily Burn Rate: $3.7K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 4
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: CHEMISTRY/IMMUNOASSAY
Place of Performance
Location: SAN DIEGO, SAN DIEGO County, CALIFORNIA, 92134
Plain-Language Summary
Department of Defense obligated $6.7 million to ABBOTT LABORATORIES INC. for work described as: CHEMISTRY/IMMUNOASSAY Key points: 1. Contract awarded to Abbott Laboratories Inc. for analytical laboratory instruments. 2. Significant contract value of $6.7 million over five years. 3. Competition method was 'Full and Open', suggesting potential for competitive pricing. 4. Sector is Defense Health Agency, indicating a critical healthcare support role.
Value Assessment
Rating: good
The contract value of $6.7 million over five years appears reasonable for specialized analytical laboratory instruments. Benchmarking against similar contracts for advanced diagnostic equipment would provide further validation.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, which typically fosters competitive pricing and ensures the government receives best value. The use of a Delivery Order under a larger contract structure suggests a streamlined procurement process.
Taxpayer Impact: Full and open competition aims to maximize taxpayer value by encouraging multiple bidders, potentially leading to lower prices and higher quality goods or services.
Public Impact
Ensures availability of critical laboratory instruments for military healthcare. Supports diagnostic capabilities within the Department of Defense. Potential for technological advancements in medical analysis.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for vendor lock-in if instruments are proprietary.
- Reliance on a single manufacturer for maintenance and consumables.
Positive Signals
- Awarded under full and open competition.
- Long-term contract provides stability for supply.
Sector Analysis
This contract falls within the Defense Health Agency's procurement of medical equipment, specifically analytical laboratory instruments. Spending in this area is crucial for maintaining healthcare readiness and diagnostic capabilities for military personnel.
Small Business Impact
The data does not indicate whether small businesses were involved in this specific award. Further analysis would be needed to determine the extent of small business participation in the supply chain or as subcontractors.
Oversight & Accountability
The contract is managed by the Defense Health Agency, which is responsible for overseeing healthcare services and procurement for the DoD. Oversight would focus on delivery, performance, and adherence to contract terms.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Defense Contracting
- Defense Health Agency Programs
Risk Flags
- Potential for vendor lock-in
- Reliance on sole source for consumables/maintenance
- Technological obsolescence risk
- Limited insight into specific instrument capabilities
Tags
analytical-laboratory-instrument-manufac, department-of-defense, ca, delivery-order, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Defense awarded $6.7 million to ABBOTT LABORATORIES INC.. CHEMISTRY/IMMUNOASSAY
Who is the contractor on this award?
The obligated recipient is ABBOTT LABORATORIES INC..
Which agency awarded this contract?
Awarding agency: Department of Defense (Defense Health Agency).
What is the total obligated amount?
The obligated amount is $6.7 million.
What is the period of performance?
Start: 2021-08-01. End: 2026-07-31.
What is the specific type of analytical laboratory instrument being procured, and what are its key capabilities?
The specific type of analytical laboratory instrument is not detailed in the provided data, but it falls under the NAICS code 334516 for Analytical Laboratory Instrument Manufacturing. These instruments are likely used for complex chemical and biological analyses, crucial for medical diagnostics within military healthcare settings.
What are the potential risks associated with relying on Abbott Laboratories Inc. for these critical instruments over a five-year period?
Potential risks include dependence on a single supplier for maintenance, repairs, and consumables, which could lead to higher long-term costs or supply chain disruptions. There's also a risk of technological obsolescence if newer, more advanced instruments become available during the contract period.
How does the pricing of these instruments compare to commercial off-the-shelf (COTS) equivalents, and does the 'full and open competition' ensure optimal value?
The provided data does not include specific pricing details or comparisons to COTS equivalents. However, 'full and open competition' is designed to solicit bids from all responsible sources, theoretically driving down prices and ensuring the government secures the best value through a competitive bidding process.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: N6264521R0010
Offers Received: 4
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 100 ABBOTT PARK RD DEPT 943 BLDG AP6C-3, NORTH CHICAGO, IL, 60064
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $6,992,151
Exercised Options: $6,992,151
Current Obligation: $6,702,151
Actual Outlays: $520,606
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: 36F79719D0024
IDV Type: FSS
Timeline
Start Date: 2021-08-01
Current End Date: 2026-07-31
Potential End Date: 2026-07-31 00:00:00
Last Modified: 2025-12-18
More Contracts from Abbott Laboratories Inc.
- Laboratory Assay for Traumatic Brain Injury — $37.6M (Department of Defense)
- Uch-L1 Promising Pairs — $31.5M (Department of Defense)
- Visn 9 Chemistry Automation Cost PER Results Reportable — $11.4M (Department of Veterans Affairs)
- Chemical Analyzer — $10.1M (Department of Veterans Affairs)
- LAB Chemistry Services — $9.4M (Department of Veterans Affairs)
Other Department of Defense Contracts
- Federal Contract — $51.3B (Humana Government Business Inc)
- Lrip LOT 12 Advance Acquisition Contract — $35.1B (Lockheed Martin Corporation)
- SSN 802 and 803 Long Lead Time Material — $34.7B (Electric Boat Corporation)
- 200204!008532!1700!AF600 !naval AIR Systems Command !N0001902C3002 !A!N! !N! !20011026!20120430!008016958!008016958!834951691!n!lockheed Martin Corporation !lockheed Blvd !fort Worth !tx!76108!27000!439!48!fort Worth !tarrant !texas !+000026000000!n!n!018981928201!ac15!rdte/Aircraft-Eng/Manuf Develop !a1a!airframes and Spares !2ama!jast/Jsf !336411!E! !3! ! ! ! ! !99990909!B! ! !A! !a!n!r!2!002!n!1a!a!n!z! ! !N!C!N! ! ! !a!a!a!a!000!a!c!n! ! ! !Y! !N00019!0001! — $34.2B (Lockheed Martin Corporation)
- KC-X Modernization Program — $32.0B (THE Boeing Company)